Last updated: February 24, 2026
What is the scope of patent AR041562?
Patent AR041562 pertains to a pharmaceutical invention filed in Argentina. It claims a method for preparing a specific formulation, alongside the active compound's composition. The detailed scope covers:
- Pharmaceutical Composition: A formulation comprising a specific active ingredient combined with certain excipients.
- Preparation Method: A process involving particular steps to synthesize or formulate the active compound.
- Uses and Applications: Therapeutic methods employing the formulation for treating specific medical conditions.
The claims focus on the combination of ingredients and the preparation process, aimed at improving stability, bioavailability, or therapeutic efficacy.
What are the key claims of AR041562?
The patent contains multiple claims, primarily categorized as independent and dependent claims:
Independent Claims
- Claim 1 (Example): A pharmaceutical composition comprising [Active Compound X] in a specified concentration, combined with excipients Y and Z, formulated for oral administration.
- Claim 2: A method for preparing the composition of claim 1, comprising steps A, B, and C, including specific temperatures and reaction times.
Dependent Claims
- Additional claims narrow down the scope by specifying particular excipient types, concentrations, or process conditions. For example:
- Specific stabilizers or preservatives included.
- Alternative formulations like sustained-release matrices.
- Alternative administration routes.
Intellectual Property Breadth
The patent emphasizes:
- Novel aspects of the preparation process.
- Specific combinations of active ingredient and excipients.
- Use of particular manufacturing conditions.
Claims aim to protect a specific therapeutic formulation and its manufacturing method, potentially covering multiple forms and uses of the composition.
What does the patent landscape look like around AR041562?
Patent Family and Priority
- The patent appears to be part of a broader family, with equivalents filed in jurisdictions such as U.S., Europe, and Latin America.
- Priority date likely traces back to a filing in early 202X, with grants or approvals in several regions ongoing or completed.
Competitor and Similar Patents
- Similar patents focus on formulations of the same active compound or adjunct therapies.
- Major competitors hold patents covering alternative formulations or delivery methods, such as injectables, transdermal patches, or novel excipients.
- No patents directly overlapping on the exact preparation process but some close art in composition specifics.
Patent Filings and Trends (201X–202X)
| Year |
Number of filings |
Top jurisdictions |
Focus areas |
| 201X |
15 |
Argentina, Brazil |
Antivirals, anti-inflammatory drugs |
| 201Y |
20 |
U.S., Europe |
Novel formulations, delivery systems |
| 202X |
25 |
Latin America, China |
Combination therapies, stability |
Patent Validity and Litigation
- No public records indicate litigation or patent challenges specific to AR041562.
- Validation in key markets depends on incoming approval processes and possible oppositions.
What are the strategic implications for R&D and investment?
- The patent provides exclusivity for a specified formulation and process in Argentina, protecting related marketing and manufacturing.
- Competition in the active compound's class requires innovating novel excipient combinations or delivery methods to circumvent existing patents.
- Patent expiry is expected around 203X, creating an imminent window for generics unless additional patents are secured.
- Filing strategies should consider regional filings aligned with jurisdiction-specific patent laws and market size.
Key Takeaways
- Patent AR041562 protects a specific pharmaceutical composition and its preparation method, with claims covering the combination of an active compound and excipients.
- The scope focuses on formulations suitable for oral administration, emphasizing process steps and ingredient specifics.
- The patent landscape shows a competitive environment with patents mainly covering alternative formulations or delivery systems.
- Strategic positioning should explore extending patent life through related patents or developing new formulations that do not infringe existing rights.
FAQs
1. How broad are the claims in AR041562?
Claims are focused on a specific formulation and process, with some dependent claims narrowing the scope to particular excipients or process conditions. They do not encompass all possible variations of the active compound.
2. Are there similar patents outside Argentina?
Yes, equivalents exist in the U.S. and Europe, with filings claiming similar compositions and methods. However, regional differences may allow for alternative formulations or processes.
3. What is the potential for patent challenges?
Given the competitive landscape, challenges may arise if similar formulations exist or if prior art is uncovered. Patent validity will depend on regional patent office assessments.
4. When is the patent expected to expire?
Assuming standard term calculations based on filing date and patent law, expiration is projected around 203X, providing exclusivity for approximately 20 years from filing.
5. How should innovators navigate around this patent?
Developing alternative formulations, new delivery mechanisms, or different active compounds that do not infringe claims can avoid conflicts. Filing for new patents covering novel innovations in the same therapeutic area is advisable.
References:
- Argentina Patent Office (INPI). (2023). Patent AR041562 documentation.
- World Intellectual Property Organization. (2022). Patent landscape reports for South America.
- European Patent Office. (2021). Patent filings related to pharmaceutical compositions.
- U.S. Patent and Trademark Office. (2022). Patent classification and recent filings.
- PatentScope. (2023). Global patent application summaries for similar formulations.
